Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Vestibular neuronitis
ADR ID BADD_A04573
ADR Hierarchy
04      Ear and labyrinth disorders
04.04      Inner ear and VIIIth cranial nerve disorders
04.04.04      VIIIth cranial nerve disorders
04.04.04.002      Vestibular neuronitis
11      Infections and infestations
11.05      Viral infectious disorders
11.05.04      Viral infections NEC
11.05.04.025      Vestibular neuronitis
17      Nervous system disorders
17.02      Neurological disorders NEC
17.02.12      Vertigos NEC
17.02.12.006      Vestibular neuronitis
Description Idiopathic inflammation of the VESTIBULAR NERVE, characterized clinically by the acute or subacute onset of VERTIGO; NAUSEA; and imbalance. The COCHLEAR NERVE is typically spared and HEARING LOSS and TINNITUS do not usually occur. Symptoms usually resolve over a period of days to weeks. (Adams et al., Principles of Neurology, 6th ed, p304) [MeSH]
MedDRA Code 10047393
MeSH ID D020338; D000160
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Epidemic vertigo | Vestibular neuronitis | Vestibular paralysis | Acoustic neuritis | Vestibular neuritis | Cochlear neuritis | Vestibular Neuronitis | Neuronitides, Vestibular | Vestibular Neuronitides | Neuritis, Vestibular | Neuritides, Vestibular | Vestibular Neuritides | Neuronitis, Vestibular | Vestibular Nerve Neuritis | Nerve Neuritides, Vestibular | Nerve Neuritis, Vestibular | Neuritides, Vestibular Nerve | Neuritis, Vestibular Nerve | Vestibular Nerve Neuritides | Vestibular Neuritis | Epidemic Neurolabyrinthitis | Epidemic Neurolabyrinthitides | Neurolabyrinthitides, Epidemic | Neurolabyrinthitis, Epidemic | Vestibular Nerve Inflammation | Inflammation, Vestibular Nerve | Inflammations, Vestibular Nerve | Nerve Inflammation, Vestibular | Nerve Inflammations, Vestibular | Vestibular Nerve Inflammations | Subacute Vestibular Neuritis | Neuritides, Subacute Vestibular | Neuritis, Subacute Vestibular | Subacute Vestibular Neuritides | Vestibular Neuritides, Subacute | Vestibular Neuritis, Subacute | Acute Peripheral Vestibulopathy | Acute Peripheral Vestibulopathies | Peripheral Vestibulopathies, Acute | Peripheral Vestibulopathy, Acute | Vestibulopathies, Acute Peripheral | Vestibulopathy, Acute Peripheral | Acute Vestibular Neuritis | Acute Vestibular Neuritides | Neuritides, Acute Vestibular | Neuritis, Acute Vestibular | Vestibular Neuritides, Acute | Vestibular Neuritis, Acute | Recurrent Vestibular Neuritis | Neuritides, Recurrent Vestibular | Neuritis, Recurrent Vestibular | Recurrent Vestibular Neuritides | Vestibular Neuritides, Recurrent | Vestibular Neuritis, Recurrent | Recurrent Vestibulopathy | Recurrent Vestibulopathies | Vestibulopathies, Recurrent | Vestibulopathy, Recurrent | Episodic Recurrent Vertigo | Episodic Recurrent Vertigos | Recurrent Vertigo, Episodic | Recurrent Vertigos, Episodic | Vertigo, Episodic Recurrent | Vertigos, Episodic Recurrent | Vestibular Neuropathy | Neuropathies, Vestibular | Neuropathy, Vestibular | Vestibular Neuropathies
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00284Bortezomib--
The 1th Page    1    Total 1 Pages